Neogenomics (NEO) Non-Current Deferred Tax Liability (2013 - 2026)
Neogenomics (NEO) posted Non-Current Deferred Tax Liability of $17.4 million for Q1 2026, down 4.22% quarter-over-quarter from $18.2 million in Q4 2025, and down 16.79% year-on-year from $21.0 million in Q1 2025.
Neogenomics (NEO) Non-Current Deferred Tax Liability (2013 - 2026) Analysis & Trends
Neogenomics (NEO) has reported Non-Current Deferred Tax Liability for 14 consecutive years, with $17.4 million the latest figure, recorded in Q1 2026.
- Non-Current Deferred Tax Liability for Q1 2026 came in at $17.4 million, down 16.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $17.4 million (down 16.79% YoY), and the FY2025 annual result was $18.2 million, down 82.33% from the prior year.
- Non-Current Deferred Tax Liability was $17.4 million for Q1 2026 at Neogenomics, down from $18.2 million in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $129.6 million in Q4 2022 and troughed at $17.4 million in Q1 2026.
- Average Non-Current Deferred Tax Liability over 5 years is $38.0 million, with a median of $24.3 million recorded in 2023.
- Year-over-year, Non-Current Deferred Tax Liability surged 2864.97% in 2022 and tumbled 82.33% in 2025.
- Over 5 years, Non-Current Deferred Tax Liability stood at $129.6 million in 2022, then sank by 81.25% to $24.3 million in 2023, then jumped by 324.58% to $103.1 million in 2024, then sank by 82.33% to $18.2 million in 2025, then decreased by 4.22% to $17.4 million in 2026.
- Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $17.4 million in Q1 2026, $18.2 million in Q4 2025, and $20.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Neogenomics | 1.93 Bn | 1.79 Bn | 80.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.45 Mn |
| Mar 31, 2026 | 17.45 Mn |
| Dec 31, 2025 | 18.22 Mn |
| Dec 31, 2025 | 18.22 Mn |
| Sep 30, 2025 | 20.85 Mn |
| Sep 30, 2025 | 20.85 Mn |
| Jun 30, 2025 | 19.98 Mn |
| Jun 30, 2025 | 19.98 Mn |
| Mar 31, 2025 | 20.97 Mn |
| Mar 31, 2025 | 20.97 Mn |
| Dec 31, 2024 | 103.11 Mn |
| Dec 31, 2024 | 103.11 Mn |
| Sep 30, 2024 | 22.77 Mn |
| Sep 30, 2024 | 22.77 Mn |
| Jun 30, 2024 | 23.02 Mn |
| Jun 30, 2024 | 23.02 Mn |
| Mar 31, 2024 | 23.49 Mn |
| Mar 31, 2024 | 23.49 Mn |
| Dec 31, 2023 | 24.29 Mn |
| Dec 31, 2023 | 24.29 Mn |